Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2101310생성일: 2026년 10월 25일
Dichloromethane → 7-(4-chlorophenyl)-8-(2-methoxypyrimidin-5-yl)-2-((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
https://huagongshe.com/reaction/2101310
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Dichloromethane | HCID 6344 | — |
| 반응물 | Potassium Phosphate, Tribasic | HCID 62657 | — |
| 반응물 | (2-Methoxypyrimidin-4-YL)boronic acid | HCID 45785507 | — |
| 반응물 | 8-bromo-7-(4-chlorophenyl)-2-((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one | HCID 57799405 | — |
| 촉매 | Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+) | HCID 178418228 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 용매 | Ethyl Acetate | HCID 8857 | — |
| 생성물 | 7-(4-chlorophenyl)-8-(2-methoxypyrimidin-5-yl)-2-((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one | HCID 57799359 | — |
반응 단계
To a stirring solution of 8-bromo-7-(4-chlorophenyl)-2-((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one (125 mg, 0.25 mmol) in THF (4 mL) at room temperature under argon was added 2-methoxy-4-pyrimidinylboronic acid (116.0 mg, 0.75 mmol), Pd(dppf)Cl2.CH2Cl2 (23 mg, 0.025 mmol), and K3PO4 (160 mg, 0.75 mmol). The resulting suspension was purged of oxygen by bubbling with argon for 15 min, sealed in a vial under argon, heated at 90° C. for 12 h, and then cooled to room temperature. Analysis by HPLC/MS indicated that starting material was absent and one major new product had formed. The reaction mixture was diluted with EtOAc and washed once with brine. The organic layer was dried (MgSO4), filtered, and concentrated under reduced pressure. The crude product was purified by automated silica gel chromatography (eluted with EtOAc/hexanes). Pooling of the desired fractions, washing with saturated aq. NaHCO3 solution to eliminate any possible boronic acid contaminant, drying the organic phase (MgSO4), filtering and evaporation provided the title compound as a yellow solid, 147 mg, 80%. HPLC/MS: retention time=3.89 min, [M+H]+=527. 1H NMR (CDCl3): δ 8.43 (s, 2H), 7.86 (d, J=7.2 Hz, 1H), 7.72 (d, J=7.7 Hz, 1H), 7.50 (d, J=7.7 Hz, 2H), 7.13 (d, J=7.7 Hz, 2H), 6.66 (d, J=7.7 Hz, 1H), 5.25 (s, 2H), 4.01 (s, 3H), 2.76 (s, 3H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07572808B2 |
|---|
| 출처 데이터셋 | uspto-grants-2009_08 |
|---|
| ORD ID | ord-c418d1de9cd9441f93df047fae569a59 |
|---|
| 출처 메모 | uspto-grants-2009_08 |
|---|